Leslie Powell

779 total citations
8 papers, 522 citations indexed

About

Leslie Powell is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Leslie Powell has authored 8 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nephrology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Molecular Biology. Recurrent topics in Leslie Powell's work include Renal Diseases and Glomerulopathies (6 papers), Chronic Kidney Disease and Diabetes (4 papers) and Vasculitis and related conditions (2 papers). Leslie Powell is often cited by papers focused on Renal Diseases and Glomerulopathies (6 papers), Chronic Kidney Disease and Diabetes (4 papers) and Vasculitis and related conditions (2 papers). Leslie Powell collaborates with scholars based in United States and Canada. Leslie Powell's co-authors include Debbie S. Gipson, Howard Trachtman, Suzanne Vento, William E. Smoyer, Jen-Jar Lin, Paul V. Miles, John D. Mahan, Shashi Nagaraj, Larry A. Greenbaum and Lynne Yao and has published in prestigious journals such as PEDIATRICS, Kidney International and American Journal of Kidney Diseases.

In The Last Decade

Leslie Powell

7 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leslie Powell United States 6 456 146 102 101 89 8 522
Agnes Trautmann Germany 8 428 0.9× 109 0.7× 101 1.0× 168 1.7× 130 1.5× 10 581
Takashi Ando Japan 11 387 0.8× 111 0.8× 59 0.6× 107 1.1× 73 0.8× 19 502
Hazel Webb United Kingdom 8 265 0.6× 76 0.5× 85 0.8× 85 0.8× 69 0.8× 15 352
Sean Barbour Canada 11 326 0.7× 97 0.7× 61 0.6× 72 0.7× 89 1.0× 41 456
Anirban Ganguli India 9 273 0.6× 107 0.7× 56 0.5× 49 0.5× 145 1.6× 17 433
Ari Shimizu Japan 12 280 0.6× 88 0.6× 68 0.7× 52 0.5× 69 0.8× 29 381
Angelo Testa France 9 330 0.7× 77 0.5× 44 0.4× 75 0.7× 116 1.3× 14 470
Eileen Ellis United States 6 494 1.1× 115 0.8× 83 0.8× 120 1.2× 142 1.6× 11 601
Yoshitsugu Kaku Japan 11 260 0.6× 48 0.3× 43 0.4× 94 0.9× 52 0.6× 23 344
Michael van Husen Germany 8 245 0.5× 70 0.5× 55 0.5× 51 0.5× 70 0.8× 10 363

Countries citing papers authored by Leslie Powell

Since Specialization
Citations

This map shows the geographic impact of Leslie Powell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Powell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Powell more than expected).

Fields of papers citing papers by Leslie Powell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie Powell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Powell. The network helps show where Leslie Powell may publish in the future.

Co-authorship network of co-authors of Leslie Powell

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie Powell. A scholar is included among the top collaborators of Leslie Powell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie Powell. Leslie Powell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Draper, Debra A., et al.. (2012). DOD and VA Health Care: Medication Needs during Transitions May Not Be Managed for All Servicemembers.
2.
Gipson, Debbie S., Howard Trachtman, Frederick J. Kaskel, et al.. (2011). Clinical trial of focal segmental glomerulosclerosis in children and young adults. Kidney International. 80(8). 868–878. 160 indexed citations
3.
Tolleson‐Rinehart, Sue, et al.. (2011). Development of a proxy-reported pulmonary outcome scale for preterm infants with bronchopulmonary dysplasia. Health and Quality of Life Outcomes. 9(1). 55–55. 2 indexed citations
4.
Gipson, Debbie S., Howard Trachtman, Frederick J. Kaskel, et al.. (2010). Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life. Kidney International. 79(6). 678–685. 37 indexed citations
5.
Peyser, Alexandra, Leslie Powell, Debbie S. Gipson, et al.. (2010). Follow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group. BMC Nephrology. 11(1). 2–2. 26 indexed citations
6.
Gipson, Debbie S., Susan F. Massengill, Lynne Yao, et al.. (2009). Management of Childhood Onset Nephrotic Syndrome. PEDIATRICS. 124(2). 747–757. 201 indexed citations
7.
Joy, Melanie S., Debbie S. Gipson, Leslie Powell, et al.. (2009). Phase 1 Trial of Adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) Study Group. American Journal of Kidney Diseases. 55(1). 50–60. 64 indexed citations
8.
Joy, Melanie S., Debbie S. Gipson, Leslie Powell, et al.. (2008). Phase I Trial of Rosiglitazone in FSGS. Clinical Journal of the American Society of Nephrology. 4(1). 39–47. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026